AstraZeneca Seeks Edge Over Rivals in Severe Asthma Treatment

By Ben Hirschler LONDON – AstraZeneca hopes to convince doctors its experimental injection for severe asthma has an edge over two approved rivals after clinical trials data on Monday showed it worked well when given just once every two months. The drugmaker has previously flagged benralizumab, which is likely to reach the market next year,

[ Read More ]

GSK and Google Parent Forge $715 Million Bioelectronic Medicines Firm

By Ben Hirschler LONDON – GlaxoSmithKline and Google parent Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics. Verily Life Sciences – known as Google’s life sciences unit until last year – and Britain’s biggest drugmaker

[ Read More ]

Pharma Crusader Takes India’s Drug Regulators to Court

By Zeba Siddiqui NEW DELHI, March 7 – One of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion industry. Three years ago, Dinesh Thakur exposed how India’s

[ Read More ]